Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Follicular × Dexamethasone × Clear all

Phase

Status

Completed 17 Unknown 3 Terminated 3 Withdrawn 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 72 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Recurrence 14 Neoplasms 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Burkitt Lymphoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Plasma Cell 5 Lung Neoplasms 5 Leukemia, Biphenotypic, Acute 5 Immunoglobulin Light-chain Amyloidosis 5 Hodgkin Disease 5 Waldenstrom Macroglobulinemia 4 Leukemia 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, B-Cell 3 Lymphoma 3 Brain Neoplasms 3 Smoldering Multiple Myeloma 2 Renal Insufficiency 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2

Interventions

Cyclophosphamide 19 Rituximab 15 Lenalidomide 15 obinutuzumab 12 fludarabine 10 Bendamustine Hydrochloride 10 zanubrutinib 9 Magnetic Resonance Spectroscopy 9 Prednisone 8 Vincristine 7 Specimen Handling 7 Doxorubicin 7 fludarabine phosphate 6 Biopsy 4 venetoclax 3 tazemetostat 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Radiotherapy 3 tisagenlecleucel 2 loncastuximab tesirine 2 Prednisolone 2 Mycophenolic Acid 2 Leukapheresis 2 Immunotherapy, Adoptive 2 Cyclosporine 2 Blood Specimen Collection 2 Automobiles 2 treosulfan 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05849857 2023-11-01

MERLIN

Oslo University Hospital

Phase 2 Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡